NWANX
Price
$33.03
Change
+$0.43 (+1.32%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

NWANX vs RMFCX

Header iconNWANX vs RMFCX Comparison
Open Charts NWANX vs RMFCXBanner chart's image
Nationwide BNY Mellon Dyn US Eq Inc R6
Price$33.03
Change+$0.43 (+1.32%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
NWANX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWANX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWANX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. NWANX (609M). NWANX (1.71) and RMFCX (1.69) have matching dividends . NWANX was incepted earlier than RMFCX: NWANX (5 years) vs RMFCX (23 years). NWANX is a more actively managed with annual turnover of: 76.61 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than NWANX: RMFCX (250) vs NWANX (1000000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. NWANX (1.13). RMFCX return over 5 years is better than : 37.80 vs. NWANX (6.39).
NWANXRMFCXNWANX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD0.3179.9213%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets609M102B1%
Annual Yield % from dividends1.711.69101%
Returns for 1 year1.1311.1110%
Returns for 3 years-0.1612.38-1%
Returns for 5 years6.3937.8017%
Returns for 10 yearsN/A59.36-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA